Immediate Impact
4 by Nobel laureates 4 from Science/Nature 50 standout
Citing Papers
Efficacy and safety of the muscarinic receptor agonist KarXT (xanomeline–trospium) in schizophrenia (EMERGENT-2) in the USA: results from a randomised, double-blind, placebo-controlled, flexible-dose phase 3 trial
2023 Standout
Cancer neuroscience: State of the field, emerging directions
2023 Standout
Works of Scott C. Mayer being referenced
Pharmacological comparison of muscarinic ligands: Historical versus more recent muscarinic M1-preferring receptor agonists
2009
Direct Inhibition ofIhby Analgesic Loperamide in Rat DRG Neurons
2007
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Scott C. Mayer | 268 | 175 | 8 | 98 | 25 | 454 | |
| Kenji Kuromizu | 337 | 123 | 54 | 58 | 29 | 436 | |
| Antonio Limatola | 247 | 90 | 25 | 64 | 16 | 467 | |
| Joseph J. Oleynek | 226 | 78 | 3 | 103 | 14 | 442 | |
| Graham N. Maw | 209 | 238 | 12 | 77 | 28 | 462 | |
| Niall M. Hamilton | 236 | 142 | 17 | 111 | 29 | 462 | |
| Sumiko Tanaka | 145 | 55 | 10 | 96 | 21 | 389 | |
| Ghazi M. Rahman | 278 | 55 | 3 | 48 | 18 | 506 | |
| Markus Kohlmann | 216 | 99 | 46 | 17 | 23 | 498 | |
| Patrick Berna | 309 | 88 | 19 | 22 | 18 | 498 | |
| Jim D. Durbin | 234 | 94 | 3 | 37 | 15 | 434 |
All Works
Loading papers...